Host genotyping and direct-acting antiviral agents: a new era of individualized treatment strategy for hepatitis CWEI Lai65-67
Research progress of association between IL-28B gene polymorphisms and hepatitis CSUN Ya-meng, YOU Hong68-70
Progress in the development of experimental animal models of HCV infectionTAO Wan-yin, ZHANG Yan, ZHONG Jin71-74
Paying much attention to the diagnosis and treatment of HIV/HCV coinfectionTANG Xiao-ping, LI Ling-hua80-82,86
Recent progress and future prospects of direct-acting antiviral agents for chronic hepatitis CRAO Hui-ying, WEI Lai83-86
Establishment and application of HCV genotyping based on NS5B regionKONG Wei-jing, DU Shao-cai, RAO Hui-ying, YANG Rui-feng, WEI Lai87-90
Development and evaluation of HCV serotyping assayYANG Xi-qin, XIU Bing-shui, WANG Guo-hua, CHEN Kun, SONG Xiao-guo, LI Zhuo, YAN Yan, ZHANG He-qiu, PENG Rui-yun91-92,103
Association between IL-28B gene polymorphisms and liver fibrosis in patients with chronic hepatitis CCONG Rui, TONG Xiao-fei, SUN Ya-meng, YOU Hong93-95
Cytokine profiles and virological response in treatment-naive and -experienced patients with chronic HCV infectionLIU Ya-li, ZHANG Yong-hong, GUO Dan-dan, LU Jun-feng, YU Hai-bin, HUA Wei, CHEN Xin-yue96-99